Incyte's skin disease drug meets main goal in two late-stage studies-February 2024-www.financetom.com

Incyte's skin disease drug meets main goal in two late-stage studies

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Incyte's skin disease drug meets main goal in two late-stage studies

Mar 17, 2025 4:23 AM

March 17 (Reuters) - Incyte ( INCY ) said on Monday its

experimental drug has met the main goal in two separate

late-stage studies testing it in patients with an inflammatory

skin condition called hidradenitis suppurativa.

Previous page： BRIEF-Australia's ACCC Says Blackstone's Proposed Acquisition Of I'Rom Raises Concerns Next page： INSIGHT-How Musk's clout with Trump could enrich his companies

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BRIEF-Australia's ACCC Says Blackstone's Proposed Acquisition Of I'Rom Raises Concerns

Nov 9, 2024

Nov 7 (Reuters) - Australian Competition and Consumer Commission: * BLACKSTONE'S PROPOSED ACQUISITION OF I'ROM RAISES CONCERNS * OUTLINED PRELIMINARY COMPETITION CONCERNS WITH PROPOSED ACQUISITION OF I'ROM GROUP CO BY BLACKSTONE * ACCC IS CONCERNED THAT THE PROPOSED ACQUISITION IS LIKELY TO RESULT IN LOWER SERVICE QUALITY AND HIGHER PRICES FOR CUSTOMERS * CONCERNED PROPOSED ACQUISITION WOULD BE LIKELY TO...

INSIGHT-How Musk's clout with Trump could enrich his companies

Nov 9, 2024

(Updates to add Trump campaign comment, Tesla investor comment and detail about Neuralink regulation) By Marisa Taylor, Rachael Levy and Chris Kirkham Nov 6 (Reuters) - Elon Musk's backing of Donald Trump's decisive victory for a second presidency gives the billionaire entrepreneur extraordinary influence to help his companies secure favorable government treatment. Musk contributed at least $119 million to a...

China's cheap Iranian oil supply at risk from tighter Trump sanctions

Nov 9, 2024

By Chen Aizhu and Siyi Liu SINGAPORE (Reuters) -China faces a squeeze on supplies of cheap Iranian crude, which make up about 13% of imports by the world's biggest buyer of oil, if Donald Trump ramps up enforcement of sanctions on Tehran after his return as U.S. president in January. Trump, who won Tuesday's election, Edison Research projected, is expected...

US sides with Argentina in dispute over $16 billion YPF judgment

Nov 9, 2024

NEW YORK (Reuters) - The U.S. government sided with Argentina in urging a federal judge not to force the cash-strapped country to give up its 51% stake in oil and gas company YPF to partially satisfy a $16.1 billion court judgment. In a Wednesday night letter to U.S. District Judge Loretta Preska in Manhattan, the Department of Justice said it...